PEGS Boston Summit 2025: Advancing the Future of Biologics Development

The PEGS Boston Summit 2025 is set to continue its tradition of being the premier conference for biologics and protein engineering. Building on the success of past years, this event will bring together a global community of thought leaders, scientists, innovators, and professionals to discuss the latest advancements in biologics, drug development, and protein engineering.

This year’s summit will cover key areas such as protein and antibody engineering, immunotherapy, radiotherapy, and the growing influence of AI/ML in biologics research. With over 300 presentations, interactive sessions, and breakout seminars, participants will have the opportunity to engage with cutting-edge research, share ideas, and collaborate on solving some of the most pressing challenges in the field.

The exhibit hall will once again feature a wide array of top-tier product and service providers, offering attendees a hands-on look at the latest innovations in biologics. Whether you’re attending to learn from industry experts or looking for networking opportunities, the PEGS Boston Summit offers a unique environment for fostering meaningful connections and collaborations.

Why Attend PEGS Boston Summit 2025?

Comprehensive Sessions: Over 300 presentations, interactive workshops, and networking sessions focused on biologics, antibody engineering, immunotherapy, and more.

Innovative Discussions: Insight into the latest AI and machine learning applications within biologics development.

Networking Opportunities: Connect with global experts, innovators, and professionals to build partnerships and stay ahead of industry trends.

Exhibit Hall: Explore cutting-edge products and services offered by leading providers in biologics and drug development.

The PEGS Boston Summit 2025 is more than just a conference – it’s a collaborative environment where the future of biologics is shaped. Don’t miss out on this opportunity to be at the forefront of the next wave of breakthroughs in biologics development.